# Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection

> **NCT01118663** · PHASE3 · TERMINATED · sponsor: **Cumberland Pharmaceuticals** · enrollment: 17 (actual)

## Conditions studied

- Acetaminophen Overdose

## Interventions

- **DRUG:** Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free)
- **DRUG:** Acetadote

## Key facts

- **NCT ID:** NCT01118663
- **Lead sponsor:** Cumberland Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2012-11
- **Final completion:** 2013-05
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2014-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01118663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01118663, "Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01118663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*